A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...

Leslie Gammons had used a GLP-1 before, but this time things went wrong. Her online doctor increased the dosage and Gammons ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Pfizer made one thing clear this week: It's officially back in the obesity race.

They've lost weight, gotten off medication and taken control of their health without paying for a gym membership.

Markets are being jolted across asset classes as risk appetite frays. Bitcoin has cracked a key support level, deepening fears the crypto sell-off has further to run. In equities, Hims & Hers has ...

Novo Nordisk is fighting back with CagriSema, a powerful combination therapy that demonstrated 22.7% weight loss in its own Phase 3 trials. While this result is superior to the current market leader, ...

A North Carolina woman spent several days in the hospital after a GLP-1 overdose. Poison control centers report a spike in DIY injectable weight loss drug calls.

Paul Wight, fka Big Show, has undergone one of the most impressive physical transformations in pro wrestling. The man fans ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

Nicki Minaj posts controversial messages on X targeting fellow artist Lizzo's body, sales and legal controversies, sparking ...

The S&P 500 is currently up 1.02% year-to-date, while the S&P Equal Weight is up 3.71% year-to-date. Read more here.